Table 2.
Interventional and in vivo studies evaluating the antioxidant biological activity of cocoa and its derivatives.
| Substances | Subjects | Study type | Dose | Outcome | Authors |
|---|---|---|---|---|---|
| Dark chocolate | 20 healthy subjects | Interventional | 40g/day for two weeks | ↑ Epicatechin levels | [109] |
| ↓ DNA damage | |||||
| Dark chocolate | 84 subjects with risk factors of metabolic syndrome | Interventional | 2g/day for 6 months | ↓ Genotoxicity in buccal epithelial cells | [110] |
| Cocoa powder | 18 healthy subjects | Interventional | 40g/day for 1 week cocoa powder in water | ↓ NFκβ activation | [111] |
| Dark chocolate | 20 healthy subjects | Interventional | 40g/day | ↑ Serum epicatechin level | [112] |
| 20 smokers | ↓ ROS production | ||||
| ↓ 8-iso-PGF2α and NADPH oxidase activation in smokers | |||||
| Flavanol-rich cocoa | 6 Healthy subjects | Interventional | 1–4g/day for 4 weeks cocoa | ↑ Plasma epicatechin and GSH levels | [113] |
| ↓ Reduction of F2 isoprostanes levels | |||||
| Modulation of PUFA metabolism | |||||
| Cocoa extract | 24 overweight/obese middle-aged subjects | Interventional | 1.4g cocoa extract/daily for 4 weeks | ↑ Cocoa-derived metabolites in plasma | [116] |
| ↓ Systolic blood pressure | |||||
| Cocoa powder | 42 high-risk volunteers | Interventional | 40g/day for 4 weeks | ↑ HDL | [52] |
| ↓ Oxidized LDL | |||||
| Cocoa powder | 100 subjects with type 2 diabetes | Interventional | 20g/day for 6 weeks | ↓ Blood cholesterol, triglyceride, LDL | [115] |
| ↓ TNF-α, high sensitive C-reactive protein, IL-6 | |||||
| Inhibition of lipid peroxidation | |||||
| Cocoa product rich in fiber | 24 healthy subjects | Interventional | 30g/day cocoa product rich in fiber | ↑ Serum HDL | [114] |
| 20 hypercholesterolaemic subjects | ↓ Glucose, IL-1β and IL-10 | ||||
| Cocoa product rich in fiber | 21 volunteers with moderate hypercholesterolaemia | Interventional | 30g/daily for 8 weeks | ↓ Systolic and diastolic blood pressure | [114] |
| ↓ MDA values | |||||
| Dark chocolate | Sprague-dawley rats (40–60 g) | in vivo | 10% of bodies weight for 3 weeks | ↓ COX-2 expression levels | [120] |
| Regulation of proliferation index | |||||
| ↓ Lower ACF formation induced by AOM | |||||
| Cocoa extract | BALB/c mice | in vivo | 34.5 mg/kg for 2 weeks | Suppression of hepatotoxicity and inflammation | [119] |
| Early stage antifibrotic and anticarcinogenic effects | |||||
| Cocoa liquor | Streptozotocin (STZ)-induced diabetic rats | in vivo | 3.6 g/kg to 7.2 g/kg body weight by day for 40 days of cocoa liquor in water | ↓ Plasma triacylglycerol levels | [45] |
| ↑ HDL and plasma antioxidant capacity | |||||
| ↓ Lipid peroxidation in plasma and tissues | |||||
| Cocoa-rich diet | Type 2 diabetic Zucker diabetic fatty rats | in vivo | All experimental groups were provided with food and water ad libitum | Improved glucose tolerance and insulin resistance | |
| ↓ ROS levels and carbonyl content | [121] | ||||
| Polyphenol enriched cocoa powder | Prediabetic model triggered by a sucrose rich diet | in vivo | 200 mg/kg body weight by day for 3 weeks | ↓ Insulin resistance | [122] |
| ↓ Hepatic carbohydrate and lipid dysmetabolism | |||||
| ↓ Oxidative stress and inflammation | |||||
| Cocoa fiber product | Spontaneously hypertensive rats | in vivo | 200, 400, and 800 mg/kg/day by 10 weeks | ↓ Systolic blood pressure | [123] |
| ↓ Glucose, cholesterol, and triglyceride levels | |||||
| ↓ Liver and plasma MDA levels | |||||
| Cocoa-rich diet | Spontaneously hypertensive rats | in vivo | 300 mg/kg of cocoa-rich extract | ↓ Systolic blood pressure | [124] |
| Phenolic-rich extract from Cocoa liquor | Wistar rats with high-fat diet | in vivo | 2.1 g of liquor/kg to 7.2 g of liquor/kg body weight by day for 28 days | ↓ Lipid peroxidation | [77] |
| ↑ Plasma and tissue antioxidant capacities | |||||
| Cocoa powder | Sprague Dawley rats with high-fat diet | in vivo | 52–108 days with 12.5% cocoa supplementation regimes | ↓ NADPH oxidase protein levels | [125] |
| ↓ Inflammation and fibrosis | |||||
| Cocoa bean extracts | Wistar rats with high-fat diet | in vivo | 2.25–2.45% of the total diet | Improvement of physiological parameters | [105] |
| Enhancement of antioxidant status |
DNA: deoxyribonucleic acid; NFκβ: nuclear factor kappa β; ROS: reactive oxygen species; 8-iso-PGF2α: 8-iso-prostaglandin F2α; NADPH: nicotinamide adenine dinucleotide phosphate; GSH: glutathione; PUFA: polyunsaturated fatty acids; HDL: high-density lipoprotein; LDL: low-density lipoprotein; TNF-α: tumor necrosis factor alpha; IL-6: interleukin 6; IL-1β: interleukin 1β; IL-10: interleukin 10; MDA: malondialdehyde; COX-2: cyclooxygenase-2; ACF: aberrant crypt foci; AOM: azoxymethane.